| 1叶胜龙.肝癌的生物治疗[M].第2版.上海:上海科学技术出版社,1999:382-396.
2汤钊猷.临床肝癌治疗学[M].第一版.上海:上海科技教育出版社,2001:56-57.
3李明松,袁爱力.肝癌患者外周血树突状细胞免疫状态的研究[J].中国癌症研究,1998,8:85-87.
4Ninomiya T,Akbar SM,Masumoto T,et al.Dendritic cells with immature pheno-type and defective function in the peripheral blood frompatients with hepatocellular carcinoma[J].J Hepatol,1999,31:323-331.
5Chen S,Akbar SM,Tanimoto K,etal.Absence of CD83-positive mature and activa-ted dendritic cells at cancer nodules from patients with hepatocellular carcinoma:relevance to hepatocarcinogenesis[J].Cancer Lett,2000,148(1):49-257.
6张晶,董宝玮,梁萍,等.肝癌患者病灶局部免疫状况研究[J].中国肿瘤临床,2002,29:1-4.
7Seliger B,Maeurer MJ,Ferrone S.Antigen-processing machinery breakdown and tumor growth[J].Immunol Today,2000,21:455-464.
8Marincola FM,Jaffee EM,Hicklin DJ,et al.Escape of human solid tumors from T-cell recognition:Molecular mechanisms and functional significance[J].A dv Immunol,2000,74:181-273.
9Nakashima M.Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1[J].Nat Med,1999,5:938.
10Kiertscher SM,Luo J,Dubinett SM,et al.Tumors promote altered maturation and early apoptosis of monocyte2derived dendritic cells[J].J Immunol,2000,164:1269-76.
11Friedl J,Stift A,Paolini P,et al.Tumor antigen pulsed dendritic cells enhance the cytolytic activity of tumor infiltrating lymphocytes in human hepatocellular cancer[J].Cancer Biother Radiopharm,2000,15:477-486.
12秦建国,韩立本,庞家芳.原发性肝癌患者浸润淋巴细胞及其功能状态与预后的关系[J].中华医学杂志,1997,77:167.
13钱其军,吴孟超,曲增强,等.人肝癌组织肿瘤浸润淋巴细胞穿孔素、Fas配体表达的研究[J].中华病理学杂志,1998,27:99-101.
14徐青,马利林,陈瑞新.肝细胞肝癌患者围手术期免疫状况检测的临床意义[J].江苏医药,2005,31(12):886-888.
15黎乐群,苏智雄,彭民浩.手术打击对原发性肝癌病人术后免疫功能影响的研究[J].中华肝胆外科杂志,2004,10(6):420-421.
16Ikeda Y,Kajiyama K,Adachi E,et al.Early recurrence after surgeryof hepatocel-lular carcinoma[J].Hepatogastroenterology,1995,42:469-472.
17丛文铭,肝细胞癌克隆起源的分子病理学研究进展[J].中华病理学杂志,1995,24:116-118.
18王振巍,连俊彦.胸腺肽α1对肝癌围手术期免疫功能的影响[J].中华普通外科杂志,2006,21(3):229-230.
19程树群,吴孟超,陈汉,等.术后免疫治疗延缓肝癌的复发[J].中华普通外科杂志,2003,18(12):762-767. |
